The brand new $3 million Breakthrough Prize in the Life Sciences  delivered a very nice reward and well deserved recognition to eleven exceptionally creative scientists who have devoted their careers to biology and medicine. And, with five awards to be given each year, I hope this inspires other life scientists to embark on innovative and high-risk endeavors.
For this inaugural round, I’m proud to say that nine of the eleven winners were NIH grant recipients—some for more than three decades. Now, you may not have heard of most of these scientists. Quite frankly, that’s a shame. These folks have discovered fundamental principles of biology—everything from cancer causing genes to techniques for creating stem cells. These discoveries have boosted our understanding of health and disease, and led to the development of many drugs and therapies.
So these individuals really should be household names—and more of that kind of recognition would be a good thing to inspire youth to explore careers in science. In the United States, virtually everyone can list names of multiple movie stars and athletes, but two-thirds of Americans can’t name a single living scientist .
The six-pack who launched the Breakthrough Prize—Google co-founder Sergey Brin and his wife 23&Me co-founder Anne Wojcicki; Facebook CEO Mark Zuckerberg and his wife Pricilla Chan; Apple chairman Art Levinson; and Russian venture capitalist Yuri Milner—want to signal to society that science is exciting, inspiring, and respected. They want the public to appreciate those who have done so much to advance medicine.
So here’s a very brief review of what these NIH-funded researchers have done:
Cornelia I. Bargmann (Rockefeller University) used a 1 millimeter long transparent worm with just 302 neurons to explore how genes and the environment converge to trigger behavior.
David Botstein (Princeton University) developed novel methods for pinpointing disease genes by following the inheritance pattern of specific disease-linked DNA markers. He’s now trying to model all the gene activity in a single cell when it is exposed to various stimuli—like a certain nutrient.
Lewis C. Cantley (Weill Cornell Medical College) discovered that many cancers arise when the phosphoinositide 3-kinase (PI3K) pathway is disrupted. He continues to explore the role of the PI3K enzyme in breast, ovarian, and endometrial cancer, and also in diabetes.
Titia de Lange (Rockefeller University) was recognized for her work on telomeres, the protective sequences at the ends of our chromosomes. She continues to explore how loss of these structures lead to cancer and aging.
Eric S. Lander (Broad Institute of Harvard and the Massachusetts Institute of Technology) was a leader in mapping the mouse and human genomes (and many others) and he has developed many of the tools to identify disease genes in cancer and other conditions.
Charles L. Sawyers (Memorial Sloan Kettering Cancer Center) has focused on signaling pathways that drive the growth and proliferation of cancer cells—including how they become drug resistant. In particular, he focuses on developing treatments for chronic myelogenous leukemia (CML), brain, and prostate cancers.
Bert Vogelstein (Johns Hopkins University) discovered a gene that suppresses tumor formation but is inactivated in colon cancer (as well as most cancers). He’s developed models of cancer initiation and progression. These findings are being used to develop diagnostic tests for colon cancer risk.
Robert A. Weinberg (Whitehead Institute) discovered the first ‘oncogene,’ which is a gene that has ‘gone rogue’ after a mutation and then drives tumor growth. Today he continues his study of cancers and how they metastasize.
Shinya Yamanaka (Kyoto University and the Gladstone Institutes in San Francisco) won a Nobel Prize last year for figuring out how to reprogram adult skin cells and transform them into “induced pluripotent stem (iPS) cells,” which behave like embryonic stem cells.
Congratulations to all of the winners!
 Breakthrough Prize in Life Sciences: http://www.breakthroughprizeinlifesciences.org